Related references
Note: Only part of the references are listed.Identification of proresolving and inflammatory lipid mediators in human psoriasis
Alexander V. Sorokin et al.
JOURNAL OF CLINICAL LIPIDOLOGY (2018)
Psoriasis pathogenesis and the development of novel targeted immune therapies
Jason E. Hawkes et al.
JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY (2017)
Proresolving and cartilage-protective actions of resolvin D1 in inflammatory arthritis
Lucy V. Norling et al.
JCI INSIGHT (2016)
Use of Aspirin, Non-steroidal Anti-inflammatory Drugs, and Acetaminophen (Paracetamol), and Risk of Psoriasis and Psoriatic Arthritis: A Cohort Study
Shaowei Wu et al.
ACTA DERMATO-VENEREOLOGICA (2015)
Resolvin E1 inhibits dendritic cell migration in the skin and attenuates contact hypersensitivity responses
Yu Sawada et al.
JOURNAL OF EXPERIMENTAL MEDICINE (2015)
Dermal V gamma 4(+) gamma delta T Cells Possess a Migratory Potency to the Draining Lymph Nodes and Modulate CD8(+) T-Cell Activity through TNF-alpha Production
Satoshi Nakamizo et al.
JOURNAL OF INVESTIGATIVE DERMATOLOGY (2015)
Risk of serious infection in biological treatment of patients with rheumatoid arthritis: a systematic review and meta-analysis
Jasvinder A. Singh et al.
LANCET (2015)
Interplay between CXCR2 and BLT1 Facilitates Neutrophil Infiltration and Resultant Keratinocyte Activation in a Murine Model of Imiquimod-Induced Psoriasis
Hayakazu Sumida et al.
JOURNAL OF IMMUNOLOGY (2014)
IL-23 from Langerhans Cells Is Required for the Development of Imiquimod-Induced Psoriasis-Like Dermatitis by Induction of IL-17A-Producing γδ T Cells
Ryutaro Yoshiki et al.
JOURNAL OF INVESTIGATIVE DERMATOLOGY (2014)
Diet and psoriasis, part III: Role of nutritional supplements
Jillian W. Millsop et al.
JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY (2014)
Endogenous n-3 polyunsaturated fatty acids protect against imiquimod-induced psoriasis-like inflammation via the IL-17/IL-23 axis
Si Qin et al.
MOLECULAR MEDICINE REPORTS (2014)
Pro-resolving lipid mediators are leads for resolution physiology
Charles N. Serhan
NATURE (2014)
Tumor Necrosis Factor Receptor Signaling in Keratinocytes Triggers Interleukin-24-Dependent Psoriasis-like Skin Inflammation in Mice
Snehlata Kumari et al.
IMMUNITY (2013)
Deficiency in IL-17-committed Vγ4+ γδ T cells in a spontaneous Sox13-mutant CD45.1+ congenic mouse substrain provides protection from dermatitis
Elizabeth E. Gray et al.
NATURE IMMUNOLOGY (2013)
Activated regulatory T cells are the major T cell type emigrating from the skin during a cutaneous immune response in mice
Michio Tomura et al.
JOURNAL OF CLINICAL INVESTIGATION (2010)
Leukotriene B4 mediates γδ T lymphocyte migration in response to diverse stimuli
Maria Fernanda de Souza Costa et al.
JOURNAL OF LEUKOCYTE BIOLOGY (2010)
Leukocyte chemotaxis: from lysosomes to motility
Gabriela Constantin et al.
NATURE IMMUNOLOGY (2010)
CCR6 and NK1.1 distinguish between IL-17A and IFN-γ-producing γδ effector T cells
Jan D. Haas et al.
EUROPEAN JOURNAL OF IMMUNOLOGY (2009)
Imiquimod-Induced Psoriasis-Like Skin Inflammation in Mice Is Mediated via the IL-23/IL-17 Axis
Leslie van der Fits et al.
JOURNAL OF IMMUNOLOGY (2009)
Genome-wide scan reveals association of psoriasis with IL-23 and NF-κB pathways
Rajan P. Nair et al.
NATURE GENETICS (2009)
Total synthesis of resolvin E1
Narihito Ogawa et al.
TETRAHEDRON LETTERS (2009)
Leukotriene B4 receptor 1 expression on dendritic cells is required for the development of Th2 responses and allergen-induced airway hyperresponsiveness
Nobuaki Miyahara et al.
JOURNAL OF IMMUNOLOGY (2008)
Resolvin E1 regulates interleukin 23, interferon-γ and lipoxin A4 to promote the resolution of allergic airway inflammation
Oliver Haworth et al.
NATURE IMMUNOLOGY (2008)
Resolvin E1 selectively interacts with leukotriene B4 receptor BLT1 and ChemR23 to regulate inflammation
Makoto Arita et al.
JOURNAL OF IMMUNOLOGY (2007)
Interleukin-22, a TH17 cytokine, mediates IL-23-induced dermal inflammation and acanthosis
Yan Zheng et al.
NATURE (2007)
Resolution phase of inflammation: Novel endogenous anti-inflammatory and proresolving lipid mediators and pathways
Charles N. Serhan
ANNUAL REVIEW OF IMMUNOLOGY (2007)
Increase in TNF-α and inducible nitric oxide synthase-expressing dendritic cells in psoriasis and reduction with efalizumab (anti-CD11a)
MA Lowes et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2005)
Absence of leukotriene B4 receptor 1 confers resistance to airway hyperresponsiveness and Th2-type immune responses
K Terawaki et al.
JOURNAL OF IMMUNOLOGY (2005)
Resolvin E1, an endogenous lipid mediator derived from omega-3 eicosapentaenoic acid, protects against 2,4,6-trinitrobenzene sulfonic acid-induced colitis
M Arita et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2005)
Psoriasis pathophysiology: current concepts of pathogenesis
JG Krueger et al.
ANNALS OF THE RHEUMATIC DISEASES (2005)
Resolvins: A family of bioactive products of omega-3 fatty acid transformation circuits initiated by aspirin treatment that counter proinflammation signals
CN Serhan et al.
JOURNAL OF EXPERIMENTAL MEDICINE (2002)
An optical marker based on the UV-induced green-to-red photoconversion of a fluorescent protein
R Ando et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2002)
Novel functional sets of lipid-derived mediators with antiinflammatory actions generated from omega-3 fatty acids via cyclooxygenase 2-nonsteroidal antiinflammatory drugs and transcellular processing
CN Serhan et al.
JOURNAL OF EXPERIMENTAL MEDICINE (2000)